FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616409899> ?p ?o ?g. }

• W2616409899 endingPage "1445" @default.
• W2616409899 startingPage "1438" @default.
• W2616409899 abstract "ObjectiveIn 2009, the Society for Vascular Surgery (SVS) developed objective performance goals (OPGs) to define the therapeutic benchmarks in critical limb ischemia (CLI) based on outcomes from randomized trials of lower extremity bypass (LEB). Current performance relative to these benchmarks in both LEB and infrainguinal endovascular intervention (IEI) remains unknown. The objective of this study was to determine whether LEB and IEI performed for CLI in a contemporary national cohort met OPG 30-day safety thresholds.MethodsSVS OPG criteria were applied to 11,043 revascularizations for CLI performed from 2011 to 2015 in the National Surgical Quality Improvement Program (NSQIP) vascular targeted modules. Primary 30-day safety OPGs including major adverse cardiovascular events (MACEs), major adverse limb events (MALEs), and amputation were calculated for the NSQIP LEB (n = 3833) and IEI (n = 3526) cohorts as well as for subgroups at “high anatomic risk” (infrapopliteal revascularization) and “high clinical risk” (age >80 years and tissue loss). These were compared with SVS OPG benchmarks using χ2 comparisons.ResultsCompared with the SVS OPG cohort, both the NSQIP LEB and IEI cohorts had fewer patients at high anatomic risk (LEB, 51%; IEI, 27%; SVS OPG, 60%; both P < .0001). The LEB cohort had fewer patients with high clinical risk than the SVS OPG cohort (LEB, 11%; SVS OPG, 16%; P < .0001). The 30-day MALE was significantly higher in the NSQIP LEB (9.0% [8.7%-9.2%]) and IEI (9.7% [9.4%-10.0%]) cohorts compared with the SVS OPG cohort (6.1% [4.7%-9.0%]; both P ≤ .007), including significantly higher rates of amputation. MACE was significantly lower in the NSQIP LEB (4.2% [4.1%-4.3%]) and IEI (3.1% [3.0%-3.2%]) cohorts compared with the SVS OPG cohort (6.1% [4.7%-8.1%]; both P ≤ .013). Among patients at high anatomic risk, 30-day MALE was significantly higher after LEB (9.5% [9.1%-9.8%]) and IEI (11.1% [10.4-11.8%]) compared with the SVS OPG cohort (6.1% [4.2%-8.6%]; P ≤ .002). Among patients with high clinical risk, IEI was associated with lower MACE compared with the SVS OPG cohort, with similar limb-related outcomes.ConclusionsIn contemporary real-world practice, LEB and IEI for CLI failed to meet SVS OPG limb-related 30-day safety benchmarks for the entire CLI cohort as well as for the patients at high anatomic risk. Additional investigation using SVS OPGs as consistent end points is required to determine why limb-related outcomes after revascularization for CLI remain suboptimal. LEB and IEI surpassed OPG benchmarks for 30-day cardiovascular morbidity and mortality. OPGs for cardiovascular morbidity in patients undergoing revascularization for CLI deserve re-evaluation using contemporary data." @default.
• W2616409899 created "2017-05-26" @default.
• W2616409899 creator A5000622050 @default.
• W2616409899 creator A5002711959 @default.
• W2616409899 creator A5007754500 @default.
• W2616409899 creator A5014917673 @default.
• W2616409899 creator A5044570846 @default.
• W2616409899 creator A5058111361 @default.
• W2616409899 creator A5068498425 @default.
• W2616409899 date "2018-11-01" @default.
• W2616409899 modified "2023-10-16" @default.
• W2616409899 title "Lower extremity bypass and endovascular intervention for critical limb ischemia fail to meet Society for Vascular Surgery's objective performance goals for limb-related outcomes in a contemporary national cohort" @default.
• W2616409899 cites W1964417908 @default.
• W2616409899 cites W1965619852 @default.
• W2616409899 cites W1975813877 @default.
• W2616409899 cites W1984684769 @default.
• W2616409899 cites W1990802090 @default.
• W2616409899 cites W2011983013 @default.
• W2616409899 cites W2024712448 @default.
• W2616409899 cites W2024960685 @default.
• W2616409899 cites W2027221490 @default.
• W2616409899 cites W2034300898 @default.
• W2616409899 cites W2057640147 @default.
• W2616409899 cites W2057979943 @default.
• W2616409899 cites W2075061346 @default.
• W2616409899 cites W2087732120 @default.
• W2616409899 cites W2092082358 @default.
• W2616409899 cites W2111512532 @default.
• W2616409899 cites W2122523807 @default.
• W2616409899 cites W2139823928 @default.
• W2616409899 cites W2144985796 @default.
• W2616409899 cites W2153972143 @default.
• W2616409899 cites W2166856570 @default.
• W2616409899 cites W2171528518 @default.
• W2616409899 cites W2171923126 @default.
• W2616409899 cites W2172283319 @default.
• W2616409899 cites W2185467918 @default.
• W2616409899 cites W2317485625 @default.
• W2616409899 cites W2566556023 @default.
• W2616409899 cites W2616425286 @default.
• W2616409899 cites W2884926531 @default.
• W2616409899 cites W43905644 @default.
• W2616409899 doi "https://doi.org/10.1016/j.jvs.2018.03.413" @default.
• W2616409899 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29937289" @default.
• W2616409899 hasPublicationYear "2018" @default.
• W2616409899 type Work @default.
• W2616409899 sameAs 2616409899 @default.
• W2616409899 citedByCount "14" @default.
• W2616409899 countsByYear W26164098992020 @default.
• W2616409899 countsByYear W26164098992021 @default.
• W2616409899 countsByYear W26164098992022 @default.
• W2616409899 countsByYear W26164098992023 @default.
• W2616409899 crossrefType "journal-article" @default.
• W2616409899 hasAuthorship W2616409899A5000622050 @default.
• W2616409899 hasAuthorship W2616409899A5002711959 @default.
• W2616409899 hasAuthorship W2616409899A5007754500 @default.
• W2616409899 hasAuthorship W2616409899A5014917673 @default.
• W2616409899 hasAuthorship W2616409899A5044570846 @default.
• W2616409899 hasAuthorship W2616409899A5058111361 @default.
• W2616409899 hasAuthorship W2616409899A5068498425 @default.
• W2616409899 hasBestOaLocation W26164098991 @default.
• W2616409899 hasConcept C126322002 @default.
• W2616409899 hasConcept C141071460 @default.
• W2616409899 hasConcept C167135981 @default.
• W2616409899 hasConcept C168563851 @default.
• W2616409899 hasConcept C197934379 @default.
• W2616409899 hasConcept C201903717 @default.
• W2616409899 hasConcept C2776204877 @default.
• W2616409899 hasConcept C2779464278 @default.
• W2616409899 hasConcept C2781099653 @default.
• W2616409899 hasConcept C500558357 @default.
• W2616409899 hasConcept C71924100 @default.
• W2616409899 hasConcept C72563966 @default.
• W2616409899 hasConceptScore W2616409899C126322002 @default.
• W2616409899 hasConceptScore W2616409899C141071460 @default.
• W2616409899 hasConceptScore W2616409899C167135981 @default.
• W2616409899 hasConceptScore W2616409899C168563851 @default.
• W2616409899 hasConceptScore W2616409899C197934379 @default.
• W2616409899 hasConceptScore W2616409899C201903717 @default.
• W2616409899 hasConceptScore W2616409899C2776204877 @default.
• W2616409899 hasConceptScore W2616409899C2779464278 @default.
• W2616409899 hasConceptScore W2616409899C2781099653 @default.
• W2616409899 hasConceptScore W2616409899C500558357 @default.
• W2616409899 hasConceptScore W2616409899C71924100 @default.
• W2616409899 hasConceptScore W2616409899C72563966 @default.
• W2616409899 hasIssue "5" @default.
• W2616409899 hasLocation W26164098991 @default.
• W2616409899 hasLocation W26164098992 @default.
• W2616409899 hasOpenAccess W2616409899 @default.
• W2616409899 hasPrimaryLocation W26164098991 @default.
• W2616409899 hasRelatedWork W2012720002 @default.
• W2616409899 hasRelatedWork W2366666323 @default.
• W2616409899 hasRelatedWork W2602609043 @default.
• W2616409899 hasRelatedWork W2745353666 @default.
• W2616409899 hasRelatedWork W2844153221 @default.
• W2616409899 hasRelatedWork W2887936019 @default.
• W2616409899 hasRelatedWork W3005771405 @default.
• W2616409899 hasRelatedWork W3010841297 @default.

• next